Reply

Affiliations

Comment

Anthony J Lembo. Gastroenterology. 2017 May.

. 2017 May;152(6):1630-1631.

doi: 10.1053/j.gastro.2017.03.042. Epub 2017 Apr 3.

No abstract available

Comment on

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP. Lembo A, et al. Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13. Gastroenterology. 2016. PMID: 27528177 Clinical Trial.
Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Dai C, Jiang M, Sun MJ. Dai C, et al. Gastroenterology. 2017 May;152(6):1629-1630. doi: 10.1053/j.gastro.2016.09.068. Epub 2017 Apr 1. Gastroenterology. 2017. PMID: 28376323 No abstract available.